Collaboration with longevity biotech firm Aria Bioscience to translate the technology into consumer healthcare products A new orally taken, gut-based compound developed by scientists from NTU Singapore, reduces the amount of dietary fat absorbed in the intestines. This differs from most existing weight-loss drugs, which act mainly by suppressing appetite or altering glucose regulation, as well as supplements that claim to boost metabolism to burn more calories. The new techno

At ARIA Bioscience, we believe optimal health begins at the cellular level. In this article, we explore cutting-edge findings on NAD⁺—a...